Page 12 - SDIR5 Abstract book 21 12 2021.

The expression of MicroRNA-30a-3p and Estrogen Receptor β in Papillary Thyroid Cancer ............. 42

Differential Expression of VHL mRNA in Parathyroid Carcinoma and Adenoma ................................ 43
uPA/PAI-1, MMP-2, -9, IL-8 and VEGF as markers of progression in early breast cancer patients .... 44

The role of TLR4 in sporadic colorectal cancer displaying microsatellite instability .......................... 45
Triple negative breast cancer and anoikis .......................................................................................... 46

Diagnostic and prognostic potential of miR-146 gene expression in oral carcinoma ........................ 47
Analysis of alpha-1 antitrypsin expression in multidrug resistant cell lines ....................................... 48
Identification and validation of mechanism responsible for leukemia cell death treated with bis-
(salicylaldehyde)thiocarbohydrazone (BTCH1) ................................................................................... 49

Investigation of the molecular effects of palbociclib and celastrol combination treatment in
pancreatic cancer cells ........................................................................................................................ 50

MiR-93-5p expression in response to the systemic, targeted, and combinational therapy for
metastatic colorectal cancer and therapy resistance: in vitro analysis .............................................. 51
Overcoming paclitaxel-induced multidrug resistance in glioblastoma cells by using a combination of
metformin and bafilomycin A1 ........................................................................................................... 52
Anti-obesity drug Orlistat (Xenical®) induces antiangiogenic potential in breast cancer cell lines .... 53

Molecular mechanisms of nanoparticle-mediated biological effects in doxorubicin treated cells .... 54
Effect of lipid raft disruption on AQP3, AQP5, and EFGR pathway ..................................................... 55

Studying the ability of tumor multidrug-resistant cells and drug-sensitive counterparts to release
and capture extracellular vesicles ....................................................................................................... 56

I1-imidazoline receptor ligand inhibits P-glycoprotein efflux in pancreatic ductal adenocarcinoma
cells ..................................................................................................................................................... 57
Combination of sirtuin 3 and hyperoxia diminishes tumorigenic properties of MDA-MB-231 cells .. 58

Ursodeoxycholic acid influences antioxidative capacity in human breast adenocarcinoma cell line
through Nrf2-dependent axis ............................................................................................................. 59

Association between TGFB1 C-509T polymorphism and acute toxicity after radiotherapy for
prostate cancer ................................................................................................................................... 60
Impact of TGFB1 Leu10Pro polymorphism on acute radiotherapy-induced toxicity in prostate cancer
patients ............................................................................................................................................... 61
Organ preservation approach for distant located rectal cancer ........................................................ 62

NF-κB as common target gene of miRNAs related to oxidative stress and prostate cancer
radiotherapy response ........................................................................................................................ 63

In silico analysis of predictive biomarkers for neoadjuvant chemoradiotherapy in locally advanced
rectal cancer ........................................................................................................................................ 64
Clinopodium nepeta (L.) Knutze essential oil in-vitro anti-proliferative activity on PC-3, Du145 and
LS174 human cancer cell lines ............................................................................................................ 65